Biologics products developer Bacterin International Holdings, Inc. (BONE) reported a fourth-quarter net loss of $4.3 million or $0.11 per share, narrower than last year's net loss of $6.7 million or $0.18 per share.
On average, 5 analysts polled by Thomson Reuters expected the company to report a loss of $0.03 per share for the quarter. Analysts' estimates typically exclude one-time items.
Total revenue for the quarter increased 72 percent to $9.1 million from $5.3 million last year. Analysts expected revenue of $9.5 million.
The company attributed the increase in revenue primarily to its continued market penetration, driven by unique product benefits for both the patient and medical care provider, combined with the continued expansion of its direct sales force.
by RTT Staff Writer
For comments and feedback: email@example.com